Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 CBRE Group to sell Lilly’s Vacaville Bio-mfg. Plant | Contract Pharma

What are you searching for?

Sign in
Breaking News

CBRE Group to sell Lilly’s Vacaville Bio-mfg. Plant

Multi-purpose facility is among the largest bulk API manufacturing facilities for recombinant microbial biologics

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

CBRE Group, Inc. has been hired to sell Eli Lilly’s biomanufacturing plant in Vacaville, CA. The multi-purpose facility is among the largest bulk API manufacturing facilities for recombinant microbial-based biopharmaceuticals in the U.S.

The site includes a 52-acre campus, with 28 acres available for future expansion. The 78,198-sq.-ft. facility includes a downstream processing building, capable of handling complex purification steps, analytical labs for raw materials, environmental monitoring and release testing, and a mechanical workshop for equipment maintenance and calibration.

CBRE Brokerage Services Life Sciences group will direct the marketing to U.S. and international biopharma firms.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics